Heat Biologics Inc. | Key People and Executives
Jeff A. Wolf
Chairman, President & Chief Executive Officer
John James Monahan
Independent Director
John K. A. Prendergast
Lead Independent Director
Edward Byron Smith
Independent Director
Jeff A. Wolf
Chairman, President & Chief Executive Officer
Jeff T. Hutchins
Chief Operating & Scientific Officer
Ann A. Rosar
Secretary, Vice President-Finance & Controller
Vadim V. Deyev
Director-Applied Research
Janice McCourt
Executive Vice President-Business Development
George E. Peoples
Chief Medical Advisor
Melissa M. Conger
Head-Investor & Media Relations
John James Monahan
Independent Director
John K. A. Prendergast
Lead Independent Director
Edward Byron Smith
Independent Director
| Address |
801 Capitola Drive
Durham North Carolina 27713
United States
|
|
Employees
|
- |
| Website |
http://www.heatbio.com |
| Updated |
07/08/2019 |
| Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The firm's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the firm's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. |
